by valethealth | Jun 8, 2021 | Press Release
Performance Cell Manufacturing was contracted to manufacture stem cells for multiple clinical trials to treat COVID-19 induced acute respiratory distress syndrome (ARDS). The most recent clinical trial approval comes from the Brazilian Health Regulatory Agency...
by valethealth | May 13, 2021 | Press Release
Performance Cell Manufacturing was contracted to manufacture stem cells for an FDA-approved stem cell clinical trial to treat COVID-19 induced acute respiratory distress syndrome (ARDS). The clinical trial, which was developed by Personalized Stem Cells, Inc. (PSC)...
by valethealth | Apr 20, 2021 | News & Events
More patients have been treated in Sorrento Therapeutics’ COVID-19 FDA-approved clinical trial using stem cells manufactured by Performance Cell Manufacturing. In late 2020, Performance Cell Manufacturing was contracted to manufacture stem cells for an FDA-approved...
by valethealth | Mar 12, 2021 | Press Release
Performance Cell Manufacturing (PCM), a contract development and manufacturing organization, recently manufactured and is providing stem cell doses for use in an FDA approved COVID-19 clinical trial. The clinical trial, which is being conducted by Sorrento...
by valethealth | Feb 9, 2021 | Press Release
Sorrento Therapeutics (Nasdaq: SRNE, “Sorrento”) announced positive results from the first patients treated in its COVID-19 clinical trial using stem cells licensed from and provided by Personalized Stem Cells, Inc. (PSC). The stem cell platform and FDA...
